Brown Advisory’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$43.2M Buy
122,883
+581
+0.5% +$207K 0.07% 208
2025
Q4
$40M Buy
122,302
+1,704
+1% +$541K 0.06% 229
2025
Q3
$34M Sell
120,598
-663
-0.5% -$192K 0.04% 256
2025
Q2
$33.9M Buy
121,261
+812
+0.7% +$230K 0.04% 248
2025
Q1
$37.5M Sell
120,449
-241,107
-67% -$71.2M 0.05% 221
2024
Q4
$94.2M Buy
361,556
+49,109
+16% +$14.6M 0.12% 132
2024
Q3
$101M Sell
312,447
-93,354
-23% -$30.5M 0.13% 130
2024
Q2
$127M Buy
405,801
+53,102
+15% +$15.6M 0.17% 103
2024
Q1
$100M Buy
352,699
+2,371
+0.7% +$694K 0.13% 134
2023
Q4
$101M Buy
350,328
+5,475
+2% +$1.49M 0.14% 125
2023
Q3
$92.7M Buy
344,853
+5,253
+2% +$1.31M 0.15% 123
2023
Q2
$75.4M Buy
339,600
+24,732
+8% +$5.74M 0.12% 149
2023
Q1
$76.1M Buy
314,868
+15,154
+5% +$3.72M 0.13% 149
2022
Q4
$78.7M Sell
299,714
-6,711
-2% -$1.8M 0.15% 136
2022
Q3
$69.1M Buy
306,425
+6,289
+2% +$1.52M 0.13% 139
2022
Q2
$73M Buy
300,136
+13,583
+5% +$3.33M 0.14% 139
2022
Q1
$69.3M Sell
286,553
-154,819
-35% -$35.6M 0.1% 157
2021
Q4
$99.3M Buy
441,372
+194,028
+78% +$41M 0.12% 121
2021
Q3
$52.6M Buy
247,344
+55,579
+29% +$12.8M 0.08% 188
2021
Q2
$46.7M Buy
191,765
+37,068
+24% +$9.12M 0.07% 201
2021
Q1
$38.5M Buy
154,697
+27,943
+22% +$6.67M 0.07% 214
2020
Q4
$29.1M Buy
126,754
+6,333
+5% +$1.46M 0.05% 232
2020
Q3
$30.6M Buy
120,421
+1,750
+1% +$434K 0.06% 193
2020
Q2
$28M Buy
118,671
+940
+0.8% +$214K 0.07% 190
2020
Q1
$23.9M Sell
117,731
-4,641
-4% -$1.01M 0.07% 188
2019
Q4
$29.5M Sell
122,372
-539
-0.4% -$119K 0.07% 203
2019
Q3
$23.8M Buy
122,911
+4,762
+4% +$914K 0.07% 216
2019
Q2
$21.8M Sell
118,149
-131,646
-53% -$23.6M 0.06% 231
2019
Q1
$47.5M Buy
249,795
+8,132
+3% +$1.55M 0.13% 148
2018
Q4
$47M Buy
241,663
+7,796
+3% +$1.52M 0.16% 126
2018
Q3
$48.5M Buy
233,867
+4,423
+2% +$872K 0.14% 144
2018
Q2
$42.4M Buy
229,444
+43,034
+23% +$7.61M 0.13% 143
2018
Q1
$31.8M Buy
186,410
+3,452
+2% +$634K 0.1% 181
2017
Q4
$31.8M Buy
182,958
+815
+0.4% +$144K 0.1% 179
2017
Q3
$34M Sell
182,143
-477
-0.3% -$84.5K 0.11% 168
2017
Q2
$31.5M Sell
182,620
-3,180
-2% -$517K 0.1% 175
2017
Q1
$30.5M Buy
185,800
+17,249
+10% +$2.87M 0.1% 164
2016
Q4
$24.6M Buy
168,551
+5,439
+3% +$819K 0.09% 180
2016
Q3
$27.2M Buy
163,112
+332
+0.2% +$56.1K 0.09% 167
2016
Q2
$24.8M Buy
162,780
+6,353
+4% +$988K 0.09% 170
2016
Q1
$23.5M Buy
156,427
+12,729
+9% +$1.89M 0.08% 162
2015
Q4
$23.3M Buy
143,698
+785
+0.5% +$123K 0.08% 175
2015
Q3
$19.8M Buy
142,913
+10,773
+8% +$1.7M 0.07% 191
2015
Q2
$20.3M Buy
132,140
+4,705
+4% +$754K 0.07% 191
2015
Q1
$20.4M Buy
127,435
+4,029
+3% +$635K 0.06% 193
2014
Q4
$19.7M Buy
123,406
+2,341
+2% +$365K 0.06% 190
2014
Q3
$17M Sell
121,065
-7,616
-6% -$994K 0.05% 205
2014
Q2
$15.2M Sell
128,681
-1,904
-1% -$220K 0.05% 218
2014
Q1
$16.1M Buy
130,585
+123
+0.1% +$14.9K 0.05% 208
2013
Q4
$14.9M Buy
130,462
+1,821
+1% +$207K 0.05% 203
2013
Q3
$14.4M Buy
128,641
+4,007
+3% +$434K 0.05% 200
2013
Q2
$12.3M Buy
+124,634
New +$12.9M 0.05% 203

Other funds holding AMGN

Brown Advisory's AMGN Position: Q1 2026 in Review

Brown Advisory increased its Amgen (AMGN) stake by 0.48% in Q1 2026, buying an estimated $207K and bringing the position to 122,883 shares worth $43.2M. The position accounts for 0.07% of the portfolio, ranked #208.

Brown Advisory first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $127M in Q2 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Brown Advisory held 122,883 shares of Amgen worth $43.2M as of Q1 2026.
  • Brown Advisory bought 581 Amgen shares in Q1 2026, an estimated $207K.
  • Amgen made up 0.07% of Brown Advisory's portfolio in Q1 2026, its #208 holding.
  • Brown Advisory first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Brown Advisory's Amgen position peaked at $127M in Q2 2024.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.